Document Detail


Concomitant Use of Contraceptives and Potentially Teratogenic Medicinal Products: Results From a Study Using Pharmacy Dispensing Data in the Netherlands.
MedLine Citation:
PMID:  22527986     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The objective of this study was to analyze to what extent potentially teratogenic medicinal products are dispensed concomitantly with contraceptives. Data on dispensed medicinal products in this population-based study were obtained from the Dutch Foundation for Pharmaceutical Statistics. For over 178 potentially teratogenic medicinal products, concomitant use of contraceptives was assessed. The proportion of potentially teratogenic medicinal products dispensed concomitantly with a contraceptive varied significantly from 40.9% (95% CI 40.7-41.2) in 2005 to 43.4% in 2009 (95% CI 44.2-43.7). Significant differences existed as well between age categories with the lowest proportions of concomitant use of contraceptives for any potentially teratogenic drug in women aged 36 through 45 years (35.0%, 95% CI 34.9-35.1) in comparison to those aged 26 through 35 years (47.1%, 95% CI 46.9-47.3) and 15 through 25 years (53.6%, 95% CI 53.4-53.8). Although our data retrieval did not cover the use of nonpharmacological forms of contraception such as condoms and sterilization and as situations may occur during which the use of drugs with (low) teratogenic potential is a balanced decision, our results raise doubts about the safe use of medicinal products with teratogenic potential.
Authors:
Rikje Ruiter; Martina Teichert; Sabine M J M Straus; Bruno H Ch Stricker; Loes E Visser
Related Documents :
22677416 - Preparation of medicines for children-a hierarchy of classification.
20949736 - Bronchoscopic management of bronchopleural fistula.
24298206 - Acute toxicity and genotoxic activity of avocado seed extract (persea americana mill., ...
18664086 - Modification of the endoscopic management of congenital duodenal stenosis.
22541796 - Ovine cutaneous myiasis: effects on production and control.
10339176 - Managing inventories for maximum benefit.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-23
Journal Detail:
Title:  Reproductive sciences (Thousand Oaks, Calif.)     Volume:  -     ISSN:  1933-7205     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101291249     Medline TA:  Reprod Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The A118G Single-Nucleotide Polymorphism of Human ?-Opioid Receptor Gene and Use of Labor Analgesia.
Next Document:  REDD1 Expression in Placenta During Human Gestation.